(Q28372018)

2

0 references

J F Blyden

3

0 references

M Nour

4

0 references

R R Matsumoto

Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke.

5

0 references

language of work or name

English

0 references

publication date

28 January 2000

0 references

published in

Neuropharmacology

0 references

volume

39

0 references

issue

3

0 references

page(s)

407-18

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Competitive and uncompetitive N-methyl-D-aspartate antagonist discriminations in pigeons: CGS 19755 and phencyclidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Clinical pharmacology and toxicology of cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

NMDA receptors are involved at the ventrolateral nucleus tractus solitarii for termination of inspiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Structural requirements for the development of potent N-methyl-D-aspartic acid (NMDA) receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Trapping channel block of NMDA-activated responses by amantadine and memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Cellular and subcellular localization of the 2B-subunit of the NMDA receptor in the adult rat telencephalon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Anticonvulsant modification of cocaine-induced toxicity in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Further characterization of [3H]ifenprodil binding to sigma receptors in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Introduction to the role of excitatory amino acids in the actions of abused drugs: a symposium presented at the 1993 annual meeting of the College on Problems of Drug Dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

6,7-Dichloroquinoxaline-2,3-dione is a competitive antagonist specific to strychnine-insensitive [3H]glycine binding sites on the N-methyl-D-aspartate receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Glutamate receptor antagonists block cocaine-induced convulsions and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Evaluation of ADCI against convulsant and locomotor stimulant effects of cocaine: comparison with the structural analogs dizocilpine and carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Differential effects of NMDA receptor and dopamine receptor antagonists on cocaine toxicities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

The discriminative stimulus properties of (+)-HA-966, an antagonist at the glycine/N-methyl-D-aspartate receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA1021 on ischemic brain damage caused by acute subdural hematoma in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

High concentrations of the neuroleptic remoxipride block voltage-activated Na+ channels in central and peripheral nerve membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Subtype-selective antagonism of NMDA receptors by nylidrin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

Modulators of N-methyl-D-aspartate protect against diazepam- or phenobarbital-resistant cocaine convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900151-3